Dr. Nadia Ewing, MD (he/him) is a Pediatrician in Pasadena, CA with over 18 years of experience. What is your opinion of Dr. Nadia Ewing, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Nadia Ewing, MD has received over $112,206 which includes payments from the following companies:
$22,745.09 from Bayer HealthCare Pharmaceuticals Inc.
$20,885.01 from Novo Nordisk Inc
$16,568.10 from Baxter Healthcare
$10,420.24 from Genentech, Inc.
$9,711.35 from Shire North American Group Inc
$7,526.79 from Grifols USA, LLC
$7,000.25 from Baxalta US Inc
$5,530.32 from Spark Therapeutics, Inc.
$5,043.99 from CSL Behring
$4,433.00 from GENZYME CORPORATION
$1,730.00 from Grifols Shared Services North America, Inc.
$319.46 from Octapharma USA, Inc.
$112.50 from Genentech USA, Inc.
$70.45 from Biogen Idec Inc.
$55.00 from Grifols, S.A.
$54.71 from Alexion Pharmaceuticals, Inc.
Payments received by Dr. Nadia Ewing, MD were from the following categories:
$60,596.00 Consulting Fee
$37,685.73 Travel and Lodging
$5,568.54 Food and Beverage
$4,030.00 Honoraria
$2,196.81 Education
$2,129.18 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!